BIO vs MYSEW · rev $651.0M vs rev $436
BIO (BIO) versus Myseum, Inc. (MYSEW) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Myseum, Inc. (MYSEW) common stock listed on NASDAQ.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported MYSEW revenue for 2024-12-31 was $436. Net income was -$5.0M. Revenue was down 35.1% from 2023-12-31 to 2024-12-31. MYSEW currently screens at market cap $0.
BIO currently screens at market cap $0. MYSEW currently screens at market cap $0.
Not investment advice. Open the BIO and MYSEW stock pages for the full models.
Not investment advice.